trié(s) par (Pertinence décroissant(e), Titre croissant(e)) 

Article

Hypofractionated postoperative stereotactic radiotherapy for large resected brain metastases

C. Evin ; Y. Eude ; J. Jacob ; C. Jenny ; R. Bourdais ; B. Mathon ; C.A. Valery ; E. Clausse ; J.-M. Simon ; P. Maingon ; L. Feuvret |

Dans Cancer/Radiothérapie (Vol. 27, n° 2, Avril 2023)

Purpose : The aim of the present retrospective study was to report outcomes after hypofractionated stereotactic radiotherapy (HSRT) for resected brain metastases (BM). Patients and methods : We reviewed results of patients with resected BM tre[...]

Plus d'information... En ligne

Article

Long duration of immunotherapy before radiosurgery might improve intracranial control of melanoma brain metastases

C. Fenioux ; I. Troussier ; A. Amelot ; P.Y. Borius ; C.H. Canova ; E. Blais ; J.-J. Mazeron ; P. Maingon ; C.A. Valery |

Dans Cancer/Radiothérapie (Vol. 27, n° 3, Mai 2023)

Purpose Despite significant advances that have been made in management of metastatic melanoma with immune checkpoint therapy, optimal timing of combination immune checkpoint therapy and stereotactic radiosurgery is unknown. We have reported tox[...]

Plus d'information... En ligne